What is the most recent earnings date for CGTX stock?
COGNITION THERAPEUTICS INC (CGTX) last reported earnings on 3/26/2026.
NASDAQ:CGTX • US19243B1026
Past quarterly earnings results for COGNITION THERAPEUTICS INC (CGTX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.05 | -0.08 | 43.53% | 71.76% | - | - | ||
| Q3 2025 | -0.06 | -0.10 | 41.18% | 76.00% | - | - | ||
| Q2 2025 | -0.11 | -0.11 | -1.10% | 38.89% | - | - | ||
| Q1 2025 | -0.14 | -0.11 | -24.49% | 48.15% | - | - | ||
| Q4 2024 | -0.17 | -0.14 | -17.37% | 37.04% | - | - | ||
| Q3 2024 | -0.25 | -0.23 | -8.93% | -13.64% | - | - | ||
| Q2 2024 | -0.18 | -0.24 | 25.17% | -12.50% | - | - | ||
| Q1 2024 | -0.27 | -0.25 | -7.31% | -28.57% | - | - | ||
| Q4 2023 | -0.27 | -0.35 | 22.60% | -35.00% | - | - | ||
| Q3 2023 | -0.22 | -0.24 | 8.70% | 24.14% | - | - | ||
| Q2 2023 | -0.16 | -0.19 | 17.00% | 36.00% | - | - | ||
| Q1 2023 | -0.21 | -0.18 | -17.43% | -23.53% | - | - | ||
| Q4 2022 | -0.20 | -0.23 | 12.66% | 98.30% | - | - | ||
| Q3 2022 | -0.29 | -0.39 | 25.96% | 96.43% | - | - | ||
| Q2 2022 | -0.25 | -0.33 | 23.72% | - | - | - | ||
| Q1 2022 | -0.17 | -0.29 | 41.86% | - | - | - | ||
| Q4 2021 | -11.74 | -0.26 | -4,335.38% | - | - | - | ||
| Q3 2021 | -8.12 | -0.58 | -1,296.63% | - | - | - | ||
| Q2 2021 | - | - | - | - | ||||
| Q1 2021 | - | - | - | - | ||||
| Q4 2020 | - | - | - | - | ||||
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - | ||||
| Q1 2020 | - | - | - | - |
Notes
COGNITION THERAPEUTICS INC (CGTX) last reported earnings on 3/26/2026.
COGNITION THERAPEUTICS INC (CGTX) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, COGNITION THERAPEUTICS INC (CGTX) has beaten EPS estimates in 2 out of 4 releases.